Literature DB >> 19654504

Differential effects of d-amphetamine on impulsive choice in spontaneously hypertensive and Wistar-Kyoto rats.

Dennis J Hand1, Andrew T Fox, Mark P Reilly.   

Abstract

The spontaneously hypertensive rat (SHR) has been shown to exhibit three of the behavioral characteristics of attention-deficit/hyperactivity disorder: hyperactivity, attention deficit and impulsivity. This study used SHRs and a control strain to assess the effects of the commonly prescribed psychomotor stimulant, d-amphetamine, on impulsivity, defined as choice for a small, immediate over a large, delayed reinforcer. d-Amphetamine (1.0, 3.2 and 5.6 mg/kg) was administered to SHR and Wistar-Kyoto rats (WKY; their progenitor strain) before sessions of a choice task involving small, immediate and larger, delayed food reinforcers. As reported earlier, SHRs were more impulsive than WKYs (they preferred the smaller, immediate reinforcer). d-Amphetamine had no effect on preference for the SHRs, but increased choices for the small, immediate reinforcer for the WKYs at the 1.0 and 3.2 doses. Thus, d-amphetamine did not reduce impulsivity in the already impulsive SHRs, but did increase impulsivity in rats that were not already impulsive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654504     DOI: 10.1097/FBP.0b013e3283305ee1

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  18 in total

1.  Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Authors:  Patrick S Johnson; Gregory J Madden; Jeffrey S Stein
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-30       Impact factor: 3.157

2.  Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.

Authors:  Britahny M Baskin; Bríd Á Nic Dhonnchadha; Linda P Dwoskin; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2017-07-20       Impact factor: 4.530

3.  D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task.

Authors:  Jean-Charles Bizot; Nicolas Cogrel; Fabienne Massé; Virgile Chauvin; Léa Brault; Sabrina David; Fabrice Trovero
Journal:  Psychopharmacology (Berl)       Date:  2015-06-04       Impact factor: 4.530

4.  Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Brain Res       Date:  2011-05-01       Impact factor: 3.252

5.  Strain differences in delay discounting between Lewis and Fischer 344 rats at baseline and following acute and chronic administration of d-amphetamine.

Authors:  Sally L Huskinson; Christopher A Krebs; Karen G Anderson
Journal:  Pharmacol Biochem Behav       Date:  2012-02-09       Impact factor: 3.533

Review 6.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

7.  Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.

Authors:  Kathleen M Kantak; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2016-03-22       Impact factor: 3.533

8.  High impulsivity in rats predicts amphetamine conditioned place preference.

Authors:  Justin R Yates; Julie A Marusich; Cassandra D Gipson; Joshua S Beckmann; Michael T Bardo
Journal:  Pharmacol Biochem Behav       Date:  2011-07-23       Impact factor: 3.533

9.  Mechanisms of Individual Differences in Impulsive and Risky Choice in Rats.

Authors:  Kimberly Kirkpatrick; Andrew T Marshall; Aaron P Smith
Journal:  Comp Cogn Behav Rev       Date:  2015

10.  Effects of benztropine analogs on delay discounting in rats.

Authors:  Paul L Soto; Takato Hiranita
Journal:  Psychopharmacology (Berl)       Date:  2020-09-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.